Loading bill breakdown…
Loading bill breakdown…
Sponsored by Sen. Amy Klobuchar (D-MN) · 6 active : 2 Republicans, 4 Democrats
Latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the
Stop STALLING Act
This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.
The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit is subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
Members fall into . All 100 senators have enough data to score.
: only movement toward the other party counts, so members who sit further from the center than their party no longer score as swing votes.
Bars show each input from 0 to 100: ideology gap, scorecard gap, . is the seat’s partisan lean, and shows how much of the input data a score has.
Loading similar votes
Ideology is each member’s score. The cluster low on the chart includes the bill’s 7 sponsor and cosponsors in the Senate: they have already committed, so they score as entrenched.
Not applicable in the Senate. There is not enough similar voting history (weight 4.5 of 5.0 needed), so this input is left out of the score rather than counted as missing.